Author:
Sendín-Martín Mercedes,Sánchez Julián Conejo-Mir
Publisher
Springer International Publishing
Reference55 articles.
1. Alomar A, Bichel J, McRae S. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol. 2007;157:133–41. https://doi.org/10.1111/j.1365-2133.2007.07942.x.
2. Amini S, Viera MH, Valins W, Berman B. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol. 2010;3:20–34.
3. Bettencourt MS. Effect of field treatment of actinic keratosis with ingenol mebutate gel on the identification of lesions for biopsy. J Drugs Dermatol. 2015;14(8):813–8.
4. Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R, et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol. 2007;127:1647–56. https://doi.org/10.1038/sj.jid.5700776.
5. Camacho-Martinez FM. Actinic keratosis. In: European handbook of dermatological treatments. 3rd ed. Berlin: Springer; 2015. p. 19–31. https://doi.org/10.1007/978-3-662-45139-7_2.